AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
Key Highlights
- ➤Jacobi Hospital selected for ALPHA-PE Research Fund study on pulmonary embolism imaging biomarkers
- ➤Study will evaluate CT pulmonary angiography radiomics as predictors of thrombectomy success
- ➤Research will assess imaging biomarkers’ potential to predict long-term pulmonary embolism outcomes
- ➤ALPHA-PE awards range from $50,000 to $750,000 over one to three years
Expert Statements
Laura Piccinini, Senior Vice President and General Manager, Cardiovascular & International, AngioDynamics
“The selection of this proposal from Dr. Alis, Dr. Sokol and the team at Jacobi Hospital reflects the purpose of the ALPHA-PE Research Fund: supporting rigorous, physician-led research that can help close evidence gaps in pulmonary embolism care.”
Laura Piccinini, Senior Vice President and General Manager, Cardiovascular & International, AngioDynamics
“This program reinforces AngioDynamics’ commitment to partnering with the clinical community, investing in evidence generation and supporting research that may help physicians improve care for patients with PE.”
Amir Darki, MD, Co-Chair of the National PERT Research Consortium
“The PERT Consortium® is pleased to support this proposal from Dr. Alis, Dr. Sokol and their team at Jacobi Hospital through the ALPHA-PE Research Fund.”
Amir Darki, MD, Co-Chair of the National PERT Research Consortium
“Independent, investigator-driven research is essential to advancing the evidence base in pulmonary embolism.”
Amir Darki, MD, Co-Chair of the National PERT Research Consortium
“This study addresses an important clinical question and has the potential to provide insights that are meaningful to physicians, patients and the broader PE community.”
Seth I. Sokol, Dr., Jacobi Hospital
“CT pulmonary angiography is already central to the diagnosis and assessment of pulmonary embolism, but there is potentially much more information within those images than we are using today.”
Seth I. Sokol, Dr., Jacobi Hospital
“Our goal is to determine whether radiomic features can help us better understand the biology of a patient’s clot and predict how it will respond to mechanical thrombectomy.”
Seth I. Sokol, Dr., Jacobi Hospital
“If validated, this research could ultimately give physicians another tool to inform treatment decisions and support a more individualized approach to PE care.”
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
Investigator-Led Study Will Evaluate Imaging Biomarkers That May Help Predict Thrombectomy Success and Inform Long-Term PE Care
Get started
Create a free account to read the full story.